The management of vasovagal syncope.
Parry
S W
SW
Cardiovascular Investigation Unit, Department of Geriatric Medicine, Royal Victoria Infirmary, Newcastle upon Tyne, UK. S.W. Parry@ncl.ac.uk
Kenny
R A
RA
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000465:Algorithms; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D006801:Humans; D010138:Pacemaker, Artificial; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D019462:Syncope, Vasovagal / Q000209:etiology / Q000628:therapy*
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D018680:Cholinergic Antagonists; D017367:Selective Serotonin Reuptake Inhibitors